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ABSTRACT
The C-peptide of insulin was thought to be biologically inactive, but recent studies have shown
that the C-peptide causes multiple molecular and physiological effects. Evidence has shown that
C-peptide binds to a cell surface receptor, probably a G-protein coupled receptor, and that the
COOH-terminal pentapeptide is essential for binding and constitutes an active site. For a further
understanding of the detailed nature of the physiological effects of C-peptide, the receptor
structure needs to be determined. We designed an affinity column using C-peptide to try and
gain a better understanding of the biological effects by examining what proteins the affinity
column with attached C-peptide would isolate from bovine tissue samples. Since the C-peptide
was shown to be internalized in the cytosol and nucleus of kidney cells, we started with
cytoplasmic and nuclear tissue lysates obtained from bovine kidney tissue. The isolated proteins
were eluted from the beads, and separated by reducing SDS-PAGE. Protein bands of interest
were then excised from the gel, digested with trypsin, and analyzed via MALDI-TOF mass
spectrometry. We were able to identify a couple of proteins using bovine heart tissue lysates
isolated with C-peptide affinity beads. Fatty acid synthase and fatty acyl-CoA ligase were
identified. The isolation of both fatty acid synthase and long chain fatty acyl-CoA ligase
indicates that C-peptide may play a role in stimulating the production of fatty acids from excess
glucose and converting those fatty acids to triacylglycerides for storage inside muscle cells. Our
results indicate that C-peptide may be involved in modulating lipid metabolism within cells and
may play a role in determining the fate of the excess glucose that enters cells by stimulating the
production of fatty acids and conversion of those fatty acids to triacylglycerides for short-term
intracellular storage instead of sending the fatty acids to the adipose tissue for long-term storage.

xi

INTRODUCTION
Insulin is synthesized by pancreatic β cells in a proinsulin form which is then cleaved at
two positions to produce the mature insulin and the C-peptide (Figure 1). C-peptide originates
from the mid portion of proinsulin, corresponding to the A and B chains of insulin. Both mature
insulin and the C-peptide are packaged into secretory granules for storage and released in
equimolar quantities into the bloodstream in response to elevated blood glucose levels.2 It was
first thought that C-peptide’s main physiological role was in facilitating the folding of the
proinsulin molecule in a manner that allowed for the appropriate formation of the disulfide bonds
between the cysteine residues of the A- and B-chains of insulin.1

Figure 1. Synthesis of insulin.1

1

C-peptide is typically 31 amino acids in length for mammals and contains 4 to 5 acidic
residues.2 Very few species have just a single basic residue (Figure 2).3 C-peptide is a highly
variable structure and generally devoid of aromatic amino acids. C-peptide’s sequence variability
resembles relaxin, another hormone in the same protein family. Eight residues in C-peptide are
highly conserved in mammals; 1 (Glu), 3 (Glu), 6 (Gln) 11 (Glu), 12 (Leu), 26 (Leu), and 31
(Gln).2 From this conservation, one would conclude that acidic residues, especially (Glu) are
important for C-peptide function overall, as well as at specific positions.3

Figure 2. Amino acid sequences of proinsulin C-peptides from different species.3
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Many studies have failed to detect the ordered structures in C-peptide. More recent
studies have indicated that C-peptide is actually not a random coil, but contains detectable
ordered structure both free and attached to insulin and proinsulin. The presence of the C-peptide
in proinsulin influences insulin core packing evidently through the formation of some kind of
local stable structure at the C-A junction. The central region of C-peptide usually contains a
glycine rich segment that would be expected to confer great flexibility, allowing it to bend back
upon itself to form a U-shaped or hairpin structure when attached to the insulin chains in native
proinsulin (Figure 3).3-4

Figure 3. Chemical structure for proinsulin C-peptide.4
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The proinsulin C-peptide was originally thought to be biologically inactive, but the
cellular and molecular mechanisms of C-peptide activity are just now being studied. The table
below (Figure 4) illustrates the biological activity of proinsulin C-peptide.5 Specific binding sites
for C-peptide on the surface of human renal tubular cells, endothelial cells, and fibroblasts have
been observed using fluorescence correlation spectroscopy.6 The C-peptide has also been
observed to bind to a membrane receptor coupled to a pertussis toxin sensitive G-protein.7-9
Incubation of fibroblast cells with the C-peptide elicited a transient increase in the intracellular
Ca+2 concentration and stimulated mitogen-activated protein kinase (MAPK)-dependent
signaling pathways.7 Specific cellular binding of the peptide, its intracellular signaling
characteristics and end effects, including its action on eNOS, Na+/K+-ATPase and several
transcription factors, have been established for many cell systems.5

In vivo effects

In vitro effects

Renal

Membrane interaction
Specific binding in nanomolar range
Intracellular signaling
G-protein involvement
Intracellular Ca2+ ↑
PKC, MAPK, and PI-3Kγ ↑
NFкB, PPARγ, Bcl2,c-Fos, ZEB ↑
End effects
eNOS activity and protein levels ↑
Na+/K+-ATPase activity and protein levels ↑
Cell growth ↑
Apoptosis ↓
Insulinomimetic effects
Anti-thrombotic effects
Other
Disaggregation of insulin hexamers

Functional reserve ↑
Glomerular hyperfiltration ↓
Urinary albumin excretion ↓
Structural abnormalities ↓
Nerve
Conduction velocity ↑
Vibration perception ↑
Blood Flow ↑
Na+/K+-ATPase activity ↑
Hyperalgesia ↓
Structural abnormalities ↓
Circulation
Muscle blood flow ↑
Skin blood flow ↑
Myocardial blood flow and contraction rate ↑
QT interval ↓

Figure 4. Summary of clinical, in vivo animal and in vitro cellular effects of C-peptide.5
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Figure 5, pictured below, illustrates an overview of the intracellular responses to Cpeptide. Most actions can be blocked by the pre-incubation of cells with pertussis toxin, which
indicates the involvement of a Gi/Go linked protein in C-peptide signaling. This has been
confirmed by direct studies of guanosine triphosphate γS binding to a Gi protein after being
exposed to C-peptide. When C-peptide is exposed to renal tubular and endothelial cells at
physiological concentrations, there is an immediate elevation of intracellular Ca2+ concentrations.
The activation of a number of components in the MAPK, in a concentration dependent manner,
is consistently observed in all cell types exposed to C-peptide. In muscle cells, C-peptide is also
found to mirror the effects of insulin. C-peptide prompts the release of NO in the endothelial
cells in a concentration and time dependent manner. The effect occurs within a few minutes and
is abolished in Ca2+ free medium in the presence of pertussis toxin or a NOS inhibitor. Increased
expression of eNOS mRNA and protein has been demonstrated after endothelial cells were
exposed to C-peptide. eNOS expression is enhanced by MAPK dependent transcriptional
activation.5
Na+/K+-ATPase C-peptide uses a stimulatory effect on Na+/K+-ATPase activity and
protein expression in renal tubular cells. This effect is concentration dependent, could be blocked
by pertussis toxin, and is dependent on Ca2+. Secondary effects of the decreased red cell Na+/K+ATPase activity are impaired deformability of the cells, but corrected after exposure to Cpeptide. The evidence confirms support for a direct relationship between C-peptide levels and
Na+/K+-ATPase activity in renal and nerve tissue and red blood cells under in vitro and in vivo
conditions.5

5

Figure 5. Preliminary model of C-peptide signaling pathways. The influence of C-peptide on
eNOS and Na+/K+-ATPase include both activation and induction. Dashed lines indicate
insulinomimetic signaling demonstrated in muscle cells.5
C-peptide also causes activation and DNA biding of several transcription factors. Cpeptide also elicits decreased surface expression of the cell adhesion molecules P-selectin and
intercellular adhesion molecule 1 on vascular endothelium, inhibiting leucocyte-endothelium
interactions. There has also been a reported stimulatory influence on cell proliferation for renal
tubular and neuroblastoma cells. In neuroblastoma cells, there was activation of phosphoinositol
3-kinase and p38 MAPK. After C-peptide exposure, this resulted in enhanced expression and
translocation of NFкB.5
It has been shown that the COOH-terminal pentapeptide from the C-peptide appears to
mediate the effects of the C-peptide.6 The binding of the pentapeptide occurs in the low
nanomolar concentration range, and its interaction fits the classic ligand-receptor concept. For a
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further understanding of the detailed nature of the physiological effects of C-peptide, the receptor
structure will have to be determined. An experimental protocol was set up (see attached) in
which the C-peptide was used to isolate any proteins capable of binding to C-peptide.
Membrane Proteins
Cells are essential to all known life forms, with their main function being to sense and
interact with their environment or other cells and produce physiological responses. These
responses are vital to the proper functioning of cells. Cells need to process different signals
inside and outside of the cell. Signaling proteins have progressed to sense signals directly or
binding to other proteins. Different cells are programmed to sense different signals depending
on the proteins expressed in their plasma membrane. These membrane proteins enable signal
transmission, and signal modulation and diversification by undergoing conformational changes
through protein-protein interactions.10
Cellular signaling processes determine how a specific cell in an organism behaves.
Cellular signaling refers to highly evolved networks of signaling events that allow a cell to
function. These networks or cascade of events are a series of biochemical processes in which
each process is initiated by the appearance of a signal. It is then followed by sensing, processing
and transmission as another signal for the next downstream process in the signaling cascade. The
signal may be inside or outside the cell. Plasma membrane proteins usually sense and process the
extracellular signals, while soluble proteins or membrane proteins process intracellular signals.10
There are a number of different types of signaling. In endocrine signaling, signal
molecules or hormones are released by a cell and travel long distances causing an effect in a
different part of the organism. The processing of light, taste, and smell are considered endocrine.
Paracrine signaling is a short range version of endocrine signaling. In paracrine signaling, the
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signal is produced by a cell that is sensed locally and processed by the neurons. In juxtacrine
signaling, the signal is membrane bound to one cell and is sensed by a receptor that is on an
adjacent cell. Autocrine signaling is when cells release a signal outside of the cell. The signal is
sensed by a membrane protein and the same cell leading to self-stimulation, such as a breast
cancer cell releasing transforming growth factor alpha that interacts with its epidermal growth
factor. A signal generated inside the cell and sensed by another receptor outside of the cell is
known as intracrine signaling. Electrical signaling is a specialized process that propagates an
electrical potential along the length of the cell and occurs on a long spatial scale.10
There is an immense diversity of signals. Chemical signals range from very small, like
oxygen, to peptides and large proteins. Spatial separation of signaling cascades is achieved by
cells expressing different receptors on the surfaces, as well as inside the cell. Transmembrane
signal transduction is the dominant component of cellular signaling, as it enables a cell to convert
an extracellular signal into one or more intracellular signals and responses. There are three main
classes of membrane proteins that enable transmembrane signal transduction.10
ICRs are the first membrane class and are responsible for sensing neurotransmitter
molecules or voltage gradients across the membrane. As ICRs bind to the signal molecules or
sense the membrane potential, they undergo conformational changes that open or close a channel
and allow specific ions to cross through the plasma membrane.10
ECRs are a diverse class of transmembrane proteins that contain extracellular ligand
binding sites and an intracellular catalytic/enzyme-binding site with a guanylyl cyclase,
phosphatase, and serine/threonine kinase or tyrosine kinase activity.10
The last class forms the largest superfamily of membrane proteins; GPCRs. By activation
from a set of extracellular signals, GPCRs undergo conformational changes, which are
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transmitted to cytoplasmic G-proteins and β-arrestins for downstream signal transmission and
potential diversification for a physiological response. GPCRs are integral membrane proteins.
They have an extracellular N-terminus with seven transmembrane helices connected by loop
regions and use their N-terminus, extracellular loops and extracellular facing transmembrane
portions to sense their signals. They interact with the most diverse set of signals from sensory
signals (vision, taste, smell, pheromones, etc) to large signal molecules, such as other proteins.10
G-Protein Coupled Receptors
Cells have the ability to process large quantities of information transmitted by
extracellular signals, such as hormones, neurotransmitters, autacoids, growth factors, odorants,
and by physical signals, such as light. A variety of cell-surface receptors mediate their
intracellular actions by a pathway that involves activation of one or more G-proteins.11-12 GPCRs
are integral membrane proteins. They have seven transmembrane helices that are connected by
three extracellular loops and three intracellular loops, as illustrated below in Figure 6.13 GPCRs
constitute the largest family of cell surface receptors, with more than a thousand different
receptors involved in signal transmission.12
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Figure 6. Schematic diagram of the general structure of G-protein linked receptors. All receptors
of this type contain seven transmembrane α-helical regions. The loop between α helices 5 and 6,
and in some cases the loop between helices 3 and 4, which face the cytosol, are important for
interactions with the coupled G-protein. E1-E4 = extracellular loops; H1-H7 = transmembrane
domains; C1-C4 = cytosolic loops.13

G-protein coupled receptors have a common signaling pathway. The agonist binds to its
specific receptor on the cell’s surface and causes a conformational change in the receptor. This
conformational change allows the interaction with the heterotrimeric G-protein in the cell
membrane, forming a high-affinity agonist-receptor G-protein complex. The receptor G-protein
interaction catalyzes guanine nucleotide exchange on α subunit of the G-protein. This leads to
the dissociation of the G-protein complex into α and βγ subunits. The GTP-bound form of the Gprotein is the activated form. This activated form also dissociates from the receptor and activates
an effector protein that modulates levels of intracellular second messengers and transduces
signal. The dissociation of the G-protein from the receptor also reduces the affinity of the
receptor for the agonist. There have been at least 15 different G-proteins α subunits, 5 β subunits,
and 5 γ subunits identified to date. These proteins mediate the inhibition of a diverse collection
of enzymes and ion channels, including adenylyl cyclase, guanylyl cyclase, phospholipases C
and A2 and Ca2+ and K+ channels.12
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G-protein coupled receptors share a structural homology, reflecting their common
mechanism of action.11 Past molecular cloning efforts have revealed that this large protein
receptor family is characterized by seven hydrophobic stretches of 20-25 amino acids. They are
predicted to form transmembrane α helices and are connected by alternating extracellular and
intracellular loops; an example is shown in Figure 7.12

Figure 7. Primary structure of the hamster βAR showing the proposed topology of the seven
transmembrane helices. The extracellular domain is at the top of the figure.12
G-protein coupled receptors contain a number of conserved cysteine residues. It is
apparent that some of these conserved residues play a role in receptor structure. There are two
highly conserved Cys residues in the second and third extracellular loops of the receptors, as
shown previously in Figure 7. If a Val is substituted for either of the conserved cysteines, a
destabilization of the tertiary structure of both rhodopsin and βAR occurs. This destabilization
suggests that these two Cys residues have an important role in maintaining the active
11

conformation of the receptor. Analysis of rhodopsin has shown that these two residues are
involved in an intramolecular disulfide bridge that links the second and third intracellular loops
of the receptors. This puts constraint on the conformation of the extracellular domain of the
protein. The invariance of the Cys residues suggest that the disulfide bridge is a common
structural feature to the entire family of G-protein coupled receptors.12
GPCRs are integral membrane proteins that have seven transmembrane helices connected
by three extracellular loops and three intracellular loops. With ~ 800 GPCRs identified, they
form the largest surperfamily in the human genome to date.10 There are three additional groups
or classes of GPCRs, class II, III, and IV receptors. These three groups do not show the
conservation of amino acids characteristic of class I receptors.11 GPCRs can further be
organized into six families: rhodopsin, secretin, glutamate, frizzled, taste 2 and adhesion.10
The rhodopsin family is also known as Class A or Family 1. This is a diverse family
dominating the human GPCRs with ~670 out of ~800 total. This family can further be
categorized into four subfamilies: α, β, γ, and δ. The α subfamily includes the light-sensing
rhodopsin receptor, biogenic amine receptors, and cannabinoid and prostanoid receptors as well
as others. The β subfamily is mainly consistent of peptide-binding proteins. The γ subfamily
receptors bind to peptides or lipid-like molecules, such as these examples, chemokine,
angiotensin, somatostatin and opioid receptors. The δ subfamily is dominated by olfactory
receptors (~388 out of ~670) and also contains purinergic and glycoprotein-binding receptors.10
Next is the secretin/adhesion family, also known as Class B or Family 2. Secretin
receptors bind to peptide hormones, while the adhesion receptors bind to extracellular matrix
molecules based on the knowledge of receptors thus far.10
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The glutamate family, or Class C or Family 3, consists of metabotropic glutamate
receptors, γ-aminobutyric acid B receptors, sweet and umami taste receptors and calcium-sensing
receptor. One of the two taste receptor monomers combines with a third monomer to form
functional heterodimers for sweet taste or umami taste.10
The frizzled family consists of ~10 frizzled receptors that bind to Wnt glycoproteins and
a smoothened receptor that seems to function without binding to a ligand. The Taste 2 family
consists exclusively of ~25 bitter taste receptors, which share the sensing of different bitter
tastants with a different subset of receptors. These taste receptors have recently also been found
in the gastrointestinal tract. Their function in the gut is not known, but their activation has been
shown to activate gut hormonal receptors.10
The structural topologies of these different classes appear to be similarly based on
structural and sequence analysis. Figure 8 shows Families 1,2, and 3. Family 1 receptors share
some common sequence motifs, as well as some conserved prolines that are usually found in the
middle of many transmembranes producing kinks in their helices. Small molecule ligands
typically bind in the extracellular facing half of the transmembrane regions, while peptides and
proteins typically bind to the extracellular loops and the N-terminus. A highly conserved
disulfide bridge is found between the cysteines in the ECL2 and top of TM3. Family 2 receptors
do not share any sequence motifs with Family 1. This family of receptors has a long N-terminal
ectodomain that bind to ligands and contain numerous conserved cysteines. Cysteine
conservation helps the long N-terminus to form a stable tertiary structure. Family 3 receptors
have a long N-terminus and long C-terminus. Most of the Family 3 receptors use their long Nterminus to bind to endogenous ligands forming a binding pocket, sometimes referred to as a
venus fly trap.10
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Figure 8. Structural topology of the receptors within each family: Family 1, Family 2, and Family
3.10
G-protein coupled receptors function at the heart of inter- and intra-cellular regulation,
and interact with extracellular signals, usually by binding to small signaling molecules. This
ligand binding induces a change in conformation of the receptor that is transmitted to the
cytoplasmic face of the protein, enabling a coupling of the cytoplasmic face with an intracellular
heterotrimeric G-protein. The intracellular G-protein acts as an intracellular signal by activating
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or inhibiting intracellular enzymes. This model of cellular communication is so successful that
GPCRs are now used to enable the senses of taste, smell, and vision, and to control a myriad of
intracellular signaling systems. Around 1,000 of these receptors are thought to be in the human
genome. Diseases such as blindness, obesity, inflammation, depression, and hypertension among
others, can be linked to malfunctioning GPCRs. Interestingly, around half of the drug targets in
the pharmaceutical industry are also GPCRs.14
Hormones and neurotransmitters are extracellular signaling molecules that interact with a
class of membranous receptors characterized by a uniform molecular architecture of seven
transmembrane α-helices linked by extra- and intracellular peptide loops. Binding of diverse
agonists to heptahelical receptors leads to activation of a limited repertoire of heterotrimeric Gproteins, forwarding the signal to intracellular effectors such as enzymes and ion channels.
Proper functioning of a G-protein coupled receptor is based on structural determinants, which are
ultimately responsible for receptor folding, trafficking and transmembrane signaling.11
An essential prerequisite for the function of multicellular organisms is a fine-tuned
communication between the individual cells. These cells have the ability to process an enormous
amount of information related to them by hormones, neurotransmitters, autocaids, growth
factors, and odorants, which are all extracellular signals, as well as physical signals such as light.
Most of these signals do not enter the cell, but affect membranous receptors which depend on
heterotrimeric G-proteins as transducer molecules.11
Even though GPCRs have a large diversity, essentially the global structures are quite
uniform. The α-helically arranged TMs are connected by three alternating extra- (e1-e3) and
intracellular (i1-i3) peptide loops. Integral membrane proteins, such as GPCRs, are partially
buried in the non-polar environment of the lipid bilayer. The correct integration and orientation
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is guided by complex translocation machinery residing in the endoplasmic reticulum (ER).
Following an initial translocation of the N-terminal receptor portion into the ER lumen, the
folding procedure takes place in two stages.11
In stage I, hydrophobic α-helices are established across the lipid bilayer and protein
folding is predominantly driven by the hydrophobic effect. The hydrophobic amino acid residues
are oriented towards the core of the TM bundle to reduce the exposure to the lipid environment.
The TMs form a tightly packed, ring-like structure once they are inside the plasma membrane.
Stage II, consists of a functional tertiary structure that is formed by establishing specific helixhelix interactions. The identification of such specific interhelical contact sites provides
information about the relative orientation of the different helices towards each other.11

Figure 9. Schematic membrane topology and key structural features of class I and class II
GPCRs. Seven transmembrane domains are connected by three extra- and three intracellular
loops. Structural elements such as the DRY motif at the cytoplasmic end of the TM3 and
NPXXY motif in TM7 are highly conserved in the rhodopsin-like GPCR family, the class I
GPCRs (A). The glucagon/secretin-like family, class II GPCRs (B), is characterized by five
conserved cysteines within the large extracellular domain. Further conserved amino acid residues
of both receptor families (in the one-letter code) are shown in enlarged circles.11

GPCR trafficking is defined as the process of ensuing proper ER insertion. Posttranslational modification and transport is realized as a complex biological phenomenon.
Multiple membrane targeting signals are localized within the proximal (TM1-5) and distal (TM616

7) transmembrane portion as shown for the α-2A adrenergic receptor in polarized renal epithelial
cells. Small changes to GPCRs, far away from the C-terminus, can often lead to complete
retention in the cell interior. Mutations of charged amino acid residues can cause protein
retention and degradation in the ER when placed within a TM of an integral plasma membrane
protein. It is assumed that the proper installment of the structure is needed to pass a type of
intracellular quality control.11
INSTRUMENTATION
Mass Spectrometry
Mass spectrometry is an important method for characterizing proteins and a technique
used frequently in proteomics. A mass spectrometer is an instrument that uses analytical
properties for measuring m/z of ions.15 A basic schematic of a mass spectrometer consists of four
parts: a sample inlet, an ion source, a mass analyzer, and a detector (Figure 10). A sample inlet
includes high-performance liquid chromatography (HPLC), gas chromatography (GC), or
capillary electrophoresis. Examples of ion sources are MALD, ESI, fast atom bombardment
(FAB), electron impact or direct chemical ionization. The mass analyzers include a TOF, a
quadrupole, an ion trap, and a magnetic sector or ion cyclotron Fourier transform, the latter
which is also a detector. Conversion dynode, electron multiplier, microchannel plate and arrays
are all common detectors.

17

Figure 10. A basic schematic of a mass spectrometer.15
A sample is introduced using an inlet. Once inside the instrument, an ionization source
applies an electrical charge converting the molecules into ions. Two primary methods of
ionization of whole proteins are electrospray (ESI) and matrix-assisted laser
desorption/ionization (MALDI). Ions are then electrostatically propelled into the mass analyzer,
generally including three types: a liner time-of-flight (TOF), a TOF reflectron, and a Fourier
transform mass analyzer (FTMS). The ions are separated based on their differing m/z within the
analyzer. The detector converts the ion energy into electrical signals that are transmitted to a
computer program producing a mass spectrum (a graph charting the intensity v. m/z).16 For the
purpose of this paper, further detail will surround Matrix Assisted Laser Desorption Ionization
Time-of-Flight (MALDI-TOF).
MALDI-TOF
MALDI MS was first introduced by Hillenkamp and Karas in 1988 and has become a
well-known analytical tool for analyzing peptides, proteins, and numerous biomolecules such as
18

oligonucleotides, carbohydrates, natural products, and lipids. MALDI is a soft ionization
technique in which the energy from the laser is spent in volatilizing the matrix rather than
degrading the polymer (Figures 11 and 12). This technique is based upon ultraviolet absorbing
matrix. The matrix and the polymer are mixed at the molecular level in an appropriate solvent.
The solvent helps prevent aggregation of the polymer. The sample-matrix mixture is placed on
the sample probe tip, under vacuum conditions. The solvent is removed, leaving co-crystallized
polymer molecules homogenously dispersed within the matrix molecules. When the pulsed laser
beam is tuned to the appropriate frequency, the energy is transferred to the matrix which is
partially vaporized, carrying intact polymer into the vapor phase and charging the polymer
chains.17

Figure 11. A schematic of the principle of MALDI.17

19

Figure 12. A more detailed schematic of the principles of MALDI-TOF.18
A linear time of flight (TOF), as shown previously in Figure 12, is based on the
acceleration of a set of ions to a detector where all of the ions are given the same energy, but
vary in mass. The ions reach the detector at different times because of differing masses. Smaller
ions will have faster velocities and reach the detector first, while larger ions have slower
velocities, and therefore are the last to be detected. The arrival time to the detector is dependent
upon the mass, charge, and kinetic energy (KE) of the ion. KE is defined as 1/2mv2 or velocity
v= (2KE/m)1/2. Ions will travel a given distance, d, within a time, t, where t depends on their
mass-to-charge ratio.17
A TOF reflectron is shown in Figure 13. A reflectron is a device in the flight tube of a
TOF mass spectrometer that acts as an electrostatic mirror, with a series of rings. It extends the
flight length of the ions. This allows the reflector to compensate for the initial energy spreads of
the ions with the same mass. Ions with a range of kinetic energies travel through the flight tube
and spend different amounts of time in the reflectron. The reflectron corrects the kinetic energy
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distributions by using a constant electrostatic field that reflects the ion beam(s) toward the
detector. Ions with higher energies spend a longer time getting to the detector, while ions with
lesser energies of the same m/z have a shorter distance to the detector. The purpose of the
reflectron is for a higher overall mass resolution.19

Figure 13. Schematic for TOF Reflectron.19
The distribution of molecules emanating from a sample is imparted to identical
translational kinetic energies after being subjected to the same electrical potential energy
difference. The ions travel the same distance down an evacuated field free drift tube. The smaller
ions arrive at the detector in a shorter time than the more massive ions. Separated ion fractions at
the end of the drift tube are detected by an appropriate recorder that produces a signal upon
impact of each ion group. The data generated from the successive laser shots add up to provide a
TOF mass spectrum. The mass spectrum is a recording of the signal as a function of time. The
time of flight (TOF) for a molecule of mass, m, and charge, z, to travel this distance is
proportional to (m/z) ½. This relationship can be used to calculate the mass of the ions, which is
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the conversion of a TOF mass spectrum to a conventional mass spectrum and can be achieved as
shown in figure 14.18

Figure 14. Conversion of a TOF spectrum to a mass spectrum. TOF measures a particle’s m/z.
An ion with a known charge and unknown mass enters the mass spectrometer and is accelerated
by an electrical field with a known strength. The acceleration results in any given ion having the
same kinetic energy as any other ion given that they all have the same charge. The velocity of the
ion depends on the m/z.17

MALDI-TOF has the ability to provide highly accurate molecular weight information on
intact molecules and has been highly utilized in protein and peptide analyses. The ability to
generate such accurate information can be extremely useful for protein identification and
characterization.17 Recently, mass spectrometry has been combined with protease digestion to
enable peptide mass fingerprinting. Peptide Mass Fingerprinting combines enzymatic digestion,
mass spectrometry, and computer facilitated analysis for protein identification.
Peptide Mass Fingerprinting and Mascot
PMF is an analytical technique used to identify proteins by matching fragment peptide
masses to theoretical masses that are found in a known database. An unknown protein is cleaved
into smaller fragments by using a proteolytic enzyme, such as trypsin, to generate peptides. The
fragment masses are then determined using MALDI-TOF. The premise is every unique protein
has a set of unique set of peptides, therefore, unique peptide masses. These fragment masses are
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compared to a database with known protein sequence masses. Successful identification is
accomplished by matching the observed peptide masses to the theoretical masses derived from a
sequence database. Identification relies on finding a sufficient number of peptides, 5+, from the
same protein at high mass accuracy.18,20
Proteins are first isolated using two-dimensional gel electrophoresis, SDS-PAGE, or
liquid chromatography. These proteins are enzymatically or chemically cleaved. Protein samples
can be derived from SDS-PAGE and are then subject to some chemical modifications. Disulfide
bridges in proteins are reduced and cysteine amino acids are carboxymethylated chemically or
acrylamidated during the gel electrophoresis. The proteins are cut into several fragments using
proteolytic enzymes, such as trypisn. Trypsin is the most commonly used endoprotease and has
the capability of generating peptides with the average size of 8-10 amino acids, which are ideal
for mass spectrometry. Trypsin cleaves the peptides on the C-terminal side of the relatively
abundant amino acids arginine and lysine. The peptides generated using trypsin need to be
purified, concentrated and desalted before analysis on the MALDI. This is achieved using
reversed-phase microcolumns, such as ZipTips, which are prepacked. By using one of these
microcolumns, the signal-to-noise ratio can be somewhat improved. The sample droplet is then
placed on a MALDI plate, allowed to dry, and then analyzed using the instrument. 18,20
The MALDI-TOF detects the sample droplet and records a mass spectrum with
monoisotopic peaks. These peaks are then labeled, which is accomplished by using a mass
spectra analysis program such as Mascot, MS-Fit, or Profound. All three programs should yield
similar results using the same set of parameters. A successful PMF is having the identified
protein found in the database.18
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Protease

Amino Acid

Exceptions

Specificity
Trypsin

X-Lys/-Y, X-Arg/-Y

Does not cleave if Y = Pro

Endoproteinase Lys-C

X-Lys/-Y

Does not cleave if Y = Pro

Clostripain

X-Arg/-Y

Endoproteinase Asp-N

X-Asp/-Y,

Does not cleave if Y = Ser

X-cysteic acid bonds
CNBr

X-Met/-Y

Does not cleave if Y = Ser, Thr, or Cys

Glu-C (V8 Protease

X-Glu/-Y, X-Asp/-Y

Does not cleave if Y = Pro

X-Phe/-Y, X-Leu/-Y,

Does not cleave if Y = Val, Ala, Gly

(E))
Pepsin

X-Glu/-Y
Endoproteinase Arg C

X-Arg/-Y

Does not cleave if Y = Pro

Thermolysin

X-/Phe-Y, X-/Ile-Y, X-

Does not cleave if Y = Pro

/Leu-Y, X-/Ala-Y, X/Val-Y, X-/Met-Y
Chymotrypsin

Formic Acid

X-Phe/-Y, X-Tyr/-Y,

Does not cleave if Y = Met, Ile, Ser, Thr,

X-Trp/-Y, X-Leu/-Y

Val, His, Glu, Asp

X-/Asp-Y

Figure 15. Protease Specificity. Proteolysis experiments can use any of a number of enzymes to
perform digestion. The cleavage specificity of some of the different enzymes is denoted by a
slash (/) before or after the amino acid responsible for specificity. Combinations of proteases can
be used to reduce specificity and to mimic other proteases. For example, Lys-C and clostripain
together are specific for the same sites as trypsin.16
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For this study the Mascot program was utilized, which contains quite a bit of information
for doing peptide mass fingerprinting. The probability mowse score is crucial. The difference
between the random and significant protein scores needs to be as high as possible. A protein with
a score >100 is considered identified. A good rule to use is that a protein is identified with a
score of >100. A score between the highest random value, usually 60-75, and 100 displays a
good candidate protein. The second criterion which must be considered is the full protein
summary report. If one clicks the accession number of the hit, more detailed information of the
protein will be displayed. The nominal mass and pI value must match up with the experimental
data obtained from gel electrophoresis. If not, protein fragments or adducts must be investigated.
The sequence coverage and masses matched are also very important pieces of information. By
multiplying the SC and MM, the reliability of the protein is revised and considered to be
identified with a value > 300. The difference between the numbers of mass values matched
should be as small as possible. If the not, the same sample may contain other protein
components. After sorting the peptides by increasing mass, the matched and observed masses
should be compared. The most intense peaks will be assigned to the identified protein. Any
unassigned peaks could be from tryptophan oxidation, methylation of aspartic acid, and glutamic
acid rich peptides.18
Radioimmunoassay
Diabetes has always been a problem and researchers have continuously looked for new
understanding of the disease. People who have diabetes have problems metabolizing sugars due
the fact their bodies cannot make enough insulin. Insulin is the pancreatic hormone essential for
metabolizing sugars. Diabetics take injections of insulin as treatment for supplementing the
insulin their bodies do not naturally make. Two researchers, Rosalyn Yalow and Solomon
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Berson, decided to find out what actually happened once insulin was injected into the body.
Their theory was that diabetes might occur as a consequence of an unusually rapid degradation
of insulin by the enzyme insulinase. To test their hypothesis, they used [125I]insulin as a tracer.
This allowed them to detect the [125I]insulin distribution through the bodies of both diabetics and
non-diabetics by the radiationemitted.21-22
Yalow and Berson observed that diabetics who had been receiving animal insulin for a
longer period of time would keep the [125I]insulin in their bodies much longer than non-diabetics.
21-22

In those days, insulin for injection was derived from cattle. Like any other foreign object,

the body flagged the cattle insulin and attacked using antibodies. This is the normal response for
any normal functioning immune system. Yalow and Berson realized that the diabetics, who had
taken insulin from cattle previously, developed an immune response forming antibodies. These
antibodies were binding to the radio-labeled insulin, slowing down the process and making it
harder for the body to use the cattle insulin. Because of this discovery, Yalow and Berson
decided that human insulin was better suited for diabetic treatment, as the human body would not
fight off human insulin. Bacteria were engineered to produce copious amounts of human insulin.
Today nearly of all the insulin used for treatment is from genetically modified bacteria. 22
After their discovery, the pair turned to kinetics of reaction of insulin. 21 They coined the
term radioimmunoassay (RIA) for this technique.21 This method is used to quantify minute
amounts of substance by using radioactive-labeled material. 22 The basic principle uses
competitive binding as found in figure 16 below.
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Figure 16. Schematic for a RIA.22
A known quantity of the hormone of interest is tagged with a radioactive antigen, also
called a tracer. 22,24 The tracer competes with a non-radioactive antigen for a certain number of
antibody or receptor binding sites. When the amount of the unlabeled antigen is increased, the
amount of tracer bound to the antibodies decreases. The target is radioactively labeled, such as
using[125I]insulin, and bound to its specific antibodies. A known amount of antibody is to be
added. A sample, such as blood, serum or plasma, is added to begin the competition. The
competition for antibodies releases a certain amount of labeled antigens, which is proportional to
the ratio of labeled and unlabeled antigens. As the concentration of unlabeled antigen is
increased, the more it binds to the antibodies and displaces the labeled variant. The labeled and
unlabeled antigens are then separated out and the radioactivity of the free, unbound antigens is
measured.24 By subtracting the amount of radioactivity in the labeled antigens from the unlabeled
antigens, one is able to quantitate the amount of hormone in the blood, serum, or plasma
sample.22
27

Experimentally, in the past, a number of protein receptors were determined by using
different methodologies. The insulin receptor was found similarly in both the liver and fat cell
membranes using radioreceptor assay. At the time of this report in 1971, the interaction of
insulin with receptors in liver cells could only be studied by measuring the specific binding of
labeled hormone to broken-cell preparations. These binding properties could not be directly
compared with the properties of an intact system, since it was impossible to accurately measure
the insulin binding properties from liver cells. Therefore, this report illustrates the basic
properties of these binding interactions as well as the interactions observed in fat cell membranes
of the liver. In the previously mentioned report, large agarose beads were covalently bound to
insulin and tested on isolated adipose tissue cells, which suggested the insulin receptors would be
located in the superficial regions of the cell. The study resulted in identifying the location in the
plasma membrane of the fat cells.25
The methodology was very straightforward. Liver membranes were prepared in a 0.25 M
sucrose solution from homogenates using differential centrifugation, a common process for
fractioning cells, and resulted in the separation of major nuclear and mitochondrial elements. The
protocol used for insulin preparation can be found in a report by Pedro Cuatrecasas from June
1971. Insulin was iodinated at 24 °C by adding 4.0 ug of crystalline porcine zinc-insulin, in 10
µL of 0.1 M sodium phosphate buffer, pH 7.4, to 100 uL of 0.25 M sodium phosphate buffer, pH
7.4, containing 1.0 mCi of Na125I. 20 µL of chloramine-T was then added and after 40 seconds,
20 µL of sodium metabisulfite was added. 8 mL of 0.1 M sodium phosphate 0.1 % albumin
buffer was immediately added. The radioactivity precipitable by trichloracetic acid was then
determined by adding one 25 mg talc tablet, dispersing it in the solution. The solution was
centrifuged for 10 minutes at 2000 rpm, resulting in a talc pellet, which was re-suspended and

28

centrifuged 4 times with 0.1 M sodium phosphate buffer, pH, 7.4. The [125I]insulin was eluted
from the talc by adding 3 mL of 0.37 N HCl containing 6 % bovine albumin. The suspension was
centrifuged for 30 minutes at 2500 rpm and the supernatant was then neutralized by adding 0.5
mL of 1 N NaOH.26
The standard binding assay consisted of incubating fat cells at 24 °C for 20 minutes in 0.5
mL of KRB-1 % albumin containing [125I]insulin. Equilibrium was achieved within 20 minutes.
To the cells was added 3 mL of ice-cold KRB-0.1 % albumin, immediately filtered, and washed
the cells with another 10 mL, under reduced pressure, on cellulose acetate EAWP Millipore
filters. The filters were removed, cut in halves, and placed in counting vials that contained 1 mL
of 10 % sodium dodecyl sulfate. Samples were shaken for 30-40 minutes at 24 °C, and 10 mL of
the counting solution was added. The choice of membrane used was critical, because insulin can
adsorb strongly to most cellulose derivative.26
By subtracting the amount that was not displaced by high concentrations of native insulin
from the total radioactive uptake, specific binding is determined. This is proportionally related to
the concentration of iodoinsulin and independent of time or temperature of the incubation
period.25 Bound insulin was detected at very low concentrations in the liver cells.25
Since radioimmunoassay was first used to measure insulin in plasma membranes in 1960
by Yalow and Berson, as well as described previously, it has since been used for a number of
polypeptide hormones, such as ACTH. ACTH appears to bind to specific receptors on the outer
surface of cells. Adenyl cyclase, an enzyme bound to the plasma membrane, is activated by the
receptor hormone complex. Adenyl cyclase rapidly converts adenosine triphosphate to cyclic
adenosine monophosphate, which appeared to be the intracellular mediator for ACTH action. In
1970, a fast, sensitive assay was developed based on the 125I-labeled and unlabeled ACTH
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competing for binding sites specific for ACTH receptors. This method allowed ACTH in plasma
to be easily measured in a few hours, as well as being applicable to a variety of other
hormones.27
Monoiodo [125I]ACTH was prepared by labeling ACTH with 125I and separating the
iodinated ACTH from the uniodinated ACTH by chromatography on carboxymethyl cellulose.
Monoiodo [125I]ACTH retains at least half of the biological activity of native ACTH and adrenal
extracts, containing both ACTH receptors and the ACTH-sensitive adenyl cyclase.
ACTH-sensitive adrenal tumors were transplanted into mice in order to obtain adrenal receptors.
These tumors were homogenized and the fractions containing all of the ACTH-sensitive adenyl
cyclase were separated by centrifugation. The particles were then disrupted in a French pressure
cell in the presence of phosphatidylethanolamine and fluoride, and then centrifuged again. After
dialysis, the supernatant was collected and used as the ACTH receptor extract. Binding to the
adrenal receptors was highly specific. Adrenal extracts containing ACTH-sensitive cyclase
bound the hormone, while other tissue extracts were inert. While biologically active [125I]ACTH
was bound, other labeled hormones were unreactive. The extent of the ACTH derivatives
competitiveness for receptors appeared related to its biological activity. 27
A clinical study was then done using sample tubes made of flint glass and siliconized.
Sample tubes were prepared with 200 to 250 µL of adrenal extract, [125I]ACTH, and either 50 to
200 µL of the patients’ plasma or 50 to 200 µL of plasma from patients who had
hypopituitarism, where unlabeled ACTH was added to a grand total of 1 mL of volume. All
procedures were done at 1 °C. Diluent used was 0.01 M MgCl2, 0.001 M dithiothreitol, 0.1 %
human serum albumin. After an hour, ~ 10 mg of Quso was added. The Quso adsorbed the free
[125I]ACTH but not the receptor bound. The samples were centrifuged for five minutes and the
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radioactivity in the supernatant and the Quso were separately counted. In the absence of
unlabeled ACTH, the [125I]ACTH was bound to the adrenal receptors. 27
In the clinical study, plasma was taken from 19 different patients. Three of these patients
had pituitary ACTH deficiencies; hence ACTH was not detectable. Two of the patients were on
corticosteroids that caused ACTH suppression. In three of seven normal adults,
ACTH was not detected at all. Four other patients had ACTH plasma levels of up to 88 pg/mL.
In the patients with hyperadrenocorticism, ACTH plasma levels ranged from 200 pg/mL up to
10,000 pg/mL.27
This study proved successful in the attempt to determine ACTH receptors in human
plasma. This was the first time a target tissue receptor was used for measuring a polypeptide
hormone. Radioreceptor assays are advantageous based on the specificity for biologically active
ACTH. Sensitivity to the receptor is an additive bonus. This study provided a direct method for
studying the interaction of hormones with their target tissues. 27
EXPERIMENTAL
This experiment was designed to identify cellular proteins capable of binding to the Cpeptide produced from the post-translational cleavage of the proinsulin peptide. A C-peptide
affinity column was developed by attaching C-peptide to benzyloxybenzylbromide polystyrene
derived resin beads through its N-terminus. Bovine kidney, heart, and thymus tissue samples
were lysed by allowing cells to swell with hypotonic buffer, removing the cytoplasmic protein
fraction, and then releasing the nuclear proteins using a high salt buffer. The protein lysates
were then incubated with the C-peptide affinity beads to isolate the proteins capable of binding
to the C-peptide. The isolated proteins were separated by SDS-PAGE, and the proteins of
interest were excised from the gel, digested with trypsin, and identified using MALDI-TOF mass
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spectrometry peptide mapping. By identifying C-peptide binding-proteins, we hope to gain a
better understanding about the cellular processes involving C-peptide which could help to unlock
the answers as to why the C-peptide is not degraded after its purpose of folding is complete.
Upon the understanding of its purpose in the body, novel treatments could be developed to help
diabetes patients especially those suffering from Type-1.
Preparation of Pre-clear Beads
Benzyloxybenzylbromide polystyrene derived resin beads were swelled in
dichloromethane (DCM) for one hour, then they were washed three times with
dimethylformamide (DMF) and three times with lysis buffer. The pre-clear beads were stored in
lysis buffer at 4 °C.
Preparation of C-peptide Affinity Beads
The human C-peptide residues 3-33 was purchased from Sigma. The N-terminus of the
peptide was attached to a benzyloxybenzylbromide polystyrene derived resin. This process left
the C-terminal residues accessible for protein binding, since researchers in other labs had
determined that the last 5 amino acids at the C-terminus of the peptide were the most important
for biological activity. Briefly, the resin beads were swelled in DCM for one hour, then they
were washed with DMF. The beads were then incubated with the C-peptide dissolved in DMF
overnight at 4 °C with stirring. The C-peptide would attach to the resin beads through an SN2
type of reaction displacing the bromine atom. The N-terminus of a peptide and the side chain of
lysine residues would act as nucleophiles; however, there are no lysine residues in the amino acid
sequence of C-peptide making the N-terminus the only point of attachment to the resin beads.
The C-peptide beads were then washed three times with DMF, three times with DCM, and three
times with lysis buffer prior to storage in lysis buffer at 4 °C.
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Tissue Lysis
Fresh bovine kidney, heart, and thymus tissue obtained from a slaughter house was used.
A. NP-40 Lysates
Bovine tissue was lysed using a NP 40 lysis buffer (50 mM Tris-HCl, 150 mM NaCl, 1%
NP 40, pH 8.0) and manual grinding with mini grinders (Bio-Rad Ready Prep Mini Grinders).
Protease inhibitors were added to the lysis buffer. Briefly, 100 mg of tissue was homogenized in
1.0 mL of NP 40 lysis buffer by manual grinding for several minutes and then allowed to sit on
ice for 30 min to ensure optimal lysis of the tissue. The tissue lysate was then centrifuged at
12,000 G for 30 min at 4 °C, and the supernatant lysate was transferred to a clean
microcentrifuge tube. Pre-clear beads were added to the lysate to remove any proteins that had
an affinity for beads themselves prior to incubation of the lysate with C-peptide beads.

Figure 17. Preparation of NP-40 Protein Lysates.
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B. Cytoplasmic and Nuclear Tissue Lysates
Cytoplasmic and nuclear tissue lysates were prepared using the CelLytic NuCLEAR
extraction kit (Sigma) following the manufacturers protocol for protein extraction from tissues
located online at: http://www.sigmaaldrich.com/content/dam/sigmaaldrich/docs/Sigma/Bulletin/nxtractbul.pdf

Briefly,
1. Weigh out about 100 mg of tissue.
2. Prepare hypotonic lysis buffer by adding 10 μL of 0.1 M DTT and 10 μL of protease
inhibitor to 1.0 mL of isotonic lysis buffer (10 mM HEPES, 1.5 mM MgCl2, 10 mM KCl, pH
7.9)
3. Rinse tissue twice with phosphate buffered saline (PBS).
4. Resuspend tissue in 1 mL of hypotonic lysis buffer .
5. Homogenize the tissue until more than 90 % of the cells are broken.
6. Centrifuge the disrupted cells at 11,000 x g for 20 minutes.
7. Transfer the supernatant (cytoplasmic fraction) to a new tube.
8. Prepare extraction buffer by adding 1.5 μL of 0.1 M DTT and 1.5 μL of protease inhibitor to
147 μL of buffer (20 mM HEPES, 1.5 mM MgCl2, 0.42 M NaCl, 0.2 mM EDTA, 25% (v/v)
Glycerol, pH 7.9).
9. Resuspend nuclei pellet in 140 μL of extraction buffer, homogenize tissue, and shake gently
for 30 minutes.
10. Centrifuge for five minutes at 20,000 x g, then transfer supernatant (nuclear fraction) to a
new tube.
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Affinity Column Protocol
Benzyloxybenzylbromide polystyrene pre-clear beads were added to the protein lysates in
order to preclear the lysate of proteins capable of binding to the unmodified resin beads. After
incubation for one hour at room temperature (with tube rotation), the solution was centrifuged at
5,000 x g for two minutes to pellet the beads, and the supernatant was transferred to a new tube.
The beads were then washed once with PBST and twice with PBS. Finally, 30 μL of SDSPAGE loading buffer containing DTT was added to the beads.
The affinity C-peptide beads were added to the supernatant from the preclear step described
above. The solution was incubated for two hours at room temperature (with tube rotation) or
overnight at 4 °C (with tube rotation). The solution was centrifuged at 5,000 x g for two
minutes, and the supernatant was removed and discarded. The beads were then washed once
with PBST and twice with PBS. Finally, 30 μL of SDS-PAGE loading buffer containing DTT
was added to the beads.
SDS-PAGE
Proteins isolated from the protein lysates using the preclear and C-peptide beads were
separated by SDS-PAGE prior to mass spectrometric analysis. Proteins were eluted from the
beads with the addition of SDS-PAGE sample loading buffer containing DTT. The samples
were heated at 100 °C for five minutes and then loaded directly onto the gels (12%
polyacrylamide, BioRad). Briefly, proteins were separated for 30 min at 200 V using
Tris/Glycine/SDS running buffer. Proteins were visualized with Bio-Safe Coomassie Stain (BioRad).
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Legend
Beads with nothing attached.
Beads with peptide attached.
Beads with peptide and any proteins attached.

1.) Cell lysate goes into an Eppendorf tube with 30 µl of beads to pre-clear.

2.) Incubate for two hours.
3.) Remove supernatant and add to the next tube.

4.) This second tube now has cell lysate on the beads with
peptide attached. Incubate for 2 hours.
5.) Next, remove the supernatant and discard.

6.) Wash the remaining beads twice with PBS.
7.) Add 30 µl of SDS-PAGE loading buffer with DTT into
the eppendorf tube.
8.) Heat in boiling water for 10 minutes.
9.) Now load 12 µl of Precision Plus Protein Standards
Kaleidoscope onto the first lane of the SDS-PAGE gel.
10.) From here load 27 µl of the sample with loading
buffer onto the third lane of the to the SDS-PAGE gel.
11.) Run gel to completion at 200V.

Figure 18. Schematic representation of Affinity Column Protocol.
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Preparation of Tryptic Digests of Protein Samples from SDS-PAGE Bands
Protein bands from the SDS-PAGE gels were excised, reduced with DTT, treated with
iodoacetamide, and digested with trypsin overnight at room temperature following the procedure
at http://msf.ucsf.edu/protocols.html.
Briefly, the protein bands of interest were excised from the gel and chopped into small
pieces. The gel pieces were washed with 100 μL of 25 mM NH4HCO3/50% ACN three times.
Next, 30 μL of 10 mM DTT in 25 mM NH4HCO3 was added to the gel pieces and the reaction
was allowed to proceed at 56° C for one hour. The solution was removed, and 30 μL of 55 mM
iodoacetamide in 25 mM NH4HCO3 was added to the gel pieces and allowed to react for 45
minutes at room temperature in the dark. The solution was removed, and the gel pieces were
washed with 100μL of 25 mM NH4HCO3 in 50% ACN three times. The gel pieces were
overlaid with 30 μL of 25 mM NH4HCO3 buffer containing between 0.1 and 0.5 µg Promega
trypsin. Protein digestion was carried out overnight at room temperature and terminated by the
addition of acetic acid. The resulting solution of peptide fragments were extracted from the gel
pieces, purified using a C18 ZipTip, and spotted onto the MALDI sample plate for mass spectral
analysis.
Analysis of Tryptic Digests of Proteins by MALDI-TOF Mass Spectrometry
The tryptic digests of the proteins were purified with C18 ZipTips (Millipore) and analyzed on
a Bruker Autoflex MALDI-TOF mass spectrometer (Billerica, MA). Prior to analysis, the
peptide preparations (0.6 μL) were each mixed with a 50% aqueous acetonitrile solution (0.6 μl)
of saturated α-cyano-4-hydroxycinnamic acid containing 0.05 % TFA as matrix, spotted onto a
stainless steel sample plate and allowed to air dry. The mass spectra were recorded in positive
ion mode with a 60 nsec delay in the m/z range from 500 to 3500. Typically, ~1000 spectra
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were accumulated with 50 laser shots for each sample spot analyzed. The resulting peptide mass
fingerprint spectra obtained for each protein analyzed was used to identify the protein by
entering the peptide molecular weights obtained into the mascot search engine (Matrix Science
Ltd. (2008) MASCOT peptide mass fingerprint).
http://www.matrixscience.com/cgi/search_form.pl?FORMVER=2&SEARCH=PMF
RESULTS AND DISCUSSION
C-peptide is produced, processed, and secreted with insulin, and appears to exert a
biological effect separate from that of insulin. The physiological significance of the C-peptide in
normal physiology has not been fully determined. Both insulin and C-peptide secretion are lost
in Type I diabetics; however, these patients only receive insulin therapy without C-peptide
replacement. The loss of C-peptide does not appear to produce immediate negative effects in
these patients, but they do eventually develop microvascular dysfunction, such as retinopathy,
neuropathy, nephropathy, or impairments in wound healing,28-29 and C-peptide replacement
reverses microvascular dysfunction leading to neuropathy.30 Previous studies conducted by
Wahren’s group have shown that C-peptide is internalized and located to the cytosol of Swiss
3T3 (fibroblast cell line) and HEK-293 (human embryonic kidney) cells, and transport of the Cpeptide into the nucleus was also observed.31 The results from this experiment suggest that Cpeptide may function as an intracrine peptide hormone, denoting intracellular hormones giving
rise to cellular effects within the cell of synthesis or a target cell.32 This experiment was
designed to gain a better understanding of the biological effects of the C-peptide by examining
what proteins an affinity column with C-peptide attached would pull out of cell lysates. Since
the C-peptide was shown to be internalized in the cytosol and nucleus of kidney cells, we started
with cytoplasmic and nuclear tissue lysates obtained from bovine kidney tissue.
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The basic experimental protocol for this experiment is summarized in Figure 19. Cpeptide affinity beads were developed by attaching C-peptide via its N-terminus to
benzyloxybenzylbromide polystyrene derived resin beads. Bovine kidney tissue into was then
differentially lysed cytoplasmic and nuclear protein lysates using the CelLytic NuCLEAR
extraction kit (Sigma). The lysates were pre-cleared with unmodified benzyloxybenzylbromide
beads (bromo beads) for one hour at room temperature. The lysate was removed and then
incubated with C-peptide beads for two hours at room temperature. The bromo beads and the Cpeptide beads were washed with PBS, and the bound proteins were then eluted from the beads,
separated by reducing SDS-PAGE, digested with trypsin, and analyzed via MALDI-TOF mass
spectrometry.

Figure 19. Basic experimental protocol for isolating proteins from bovine kidney tissue using
C-peptide affinity beads.
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The protein bands excised from the SDS-PAGE gels were identified by mass
spectrometry through the Peptide Mass Fingerprint (PMF) technique. In PMF, an unknown
protein is cleaved into smaller peptide fragments using a specific protease, most commonly
trypsin. The molecular weight of each fragment peptide is then accurately measured by MALDITOF mass spectrometry. These peptide masses are then compared to a computer database of
known protein sequences in Mascot. In this experiment, the proteins isolated were identified via
excising a protein band from the gel, digesting the protein with trypsin, and analyzing the
resulting peptide fragments with MALDI-TOF mass spectrometry. The basic experimental
protocol for identifying the proteins by the PMF technique is shown below in Figure 20.

Figure 20. Overview of the Peptide Mass Fingerprint technique for identfying proteins by mass
spectrometry.
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Bovine Kidney Trial 1
The SDS-PAGE gel of the bovine kidney proteins isolated using the bromo beads and the
C-peptide beads can be seen in Figure 21. There were quite a few protein bands present in the
cytoplasmic and nuclear lysate lanes from both the bromo beads and the C-peptide beads. The
lysates were precleared with the bromo beads prior to incubation with the C-peptide beads. Just
in case the bromo beads did not isolate all of the proteins capable of binding to the beads
themselves, the proteins isolated from the bromo beads were eluted to get an idea of what
proteins were able to bind to these beads. In addition, a few μL of proteins from the lysates
themselves were also loaded as a control to make sure that there were indeed proteins in the
lysates. By analyzing the protein bands present in the gel, it was determined that the separation
needed to run longer in order to more fully separate the proteins. In addition, many of the
proteins in the lanes appear to be smeared indicating a possible overloading of protein onto the
gel. It also seems as if the beads were not washed sufficiently with PBS to remove proteins
bound nonspecifically to the beads prior to bound protein elution from the beads. Therefore, it
was decided to repeat this experiment and add an additional washing of the beads with PBST
prior to protein elution; also, to let the SDS-PAGE separation run longer in order to more fully
separate the proteins from one another.
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Figure 21. SDS-PAGE gel of proteins isolated from bovine kidney tissue in trial 1. The first
lane contains molecular weight protein standards.

Bovine Kidney Trial 2
The SDS-PAGE gel of the bovine kidney proteins isolated using the bromo beads and the
C-peptide beads in trial 2 of the experiment can be seen in Figure 22. Again, there were quite a
few protein bands present in the cytoplasmic and nuclear lysate lanes from both the bromo beads
and the C-peptide beads. The additional wash step with the PBST was performed for both the
bromo beads and the C-peptide beads prior to eluting the proteins from the beads with gel
loading buffer. In addition, less sample was loaded into each lane of the gel. There were distinct
protein bands within the 37 kDa-75 kDa molecular weight range from both the bromo beads and
the C-peptide beads, and many of the protein bands appeared to be overlapping between the two
bead types. Just because the protein bands appeared in the same general area of the gel for both
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bead types does not mean that they were necessarily the same protein. There are many different
proteins in a cell that have similar molecular weights, and they would not be separable from one
another using only SDS-PAGE separation. Therefore, it was decided to excise the protein bands
within this mass range from both bead types isolated from both the cytoplasmic and nuclear
lysates.

Figure 22. SDS-PAGE gel of proteins isolated from bovine kidney tissue in trial 2. The first
lane contains molecular weight protein standards.
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The MALDI-TOF mass spectrum generated from the tryptic digest of the protein at about
45 kDa in lane 4 of the SDS PAGE gel (Figure 22) is shown in Figure 23. The molecular
weights of the tryptic peptides generated from this protein were entered into the Mascot search
engine, and the protein was identified as actin. MALDI-TOF mass spectra were also obtained
for the tryptic peptides produced from the corresponding protein bands at 45 kDa in lanes 1-3 of
the gel, and the peptides generated confirmed the identity of these proteins as actin as well.
Therefore, actin was isolated using both the bromo beads and the C-peptide beads, so it is not a
unique C-peptide binding protein. Actin is the most abundant protein in most eukaryotic cells
participating in many cellular functions ranging from cell motility and the maintenance of cell
shape to the regulation of transcription.33 Actin also participates in more protein-protein
interactions than any other known protein, making it a “sticky” protein. Apparently that actin is
nonspecifically binding to the polystyrene beads and the walls of the microcentrifuge tubes, and
this interaction is then disrupted by the SDS when the tubes and beads are heated in the gel
loading buffer solution.
The protein band excised from the ~51 kDa position in lane 4 of the SDS-PAGE gel
(Figure 22) was identified as a mixture of the α and β subunits of F1-ATPase. The MALDI-TOF
mass spectrum generated from the tryptic digest of this protein is shown in Figure 24. This
protein is one of the most abundant proteins in every organism and is responsible for
synthesizing adenosine triphosphate (ATP). ATP is used to power and sustain virtually all
cellular processes needed to survive and reproduce. MALDI-TOF mass spectra were also
obtained for the tryptic peptides produced from the corresponding protein bands at ~51 kDa in
lanes 1-3 of the gel, and the peptides generated confirmed the identity of these proteins as the α
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and β subunits of F1-ATPase. Since this protein is so abundant in cells, it appears that it is just
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Figure 23. MALDI-TOF peptide fingerprint mass spectrum for the protein excised from the
band at 45 kDa in lane 4 of the SDS-PAGE gel for bovine kidney shown in Figure 22. The
protein was identified as actin.
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Figure 24. MALDI-TOF peptide fingerprint mass spectrum for the protein excised from the
band at 51 kDa in lane 4 of the SDS-PAGE gel for bovine kidney shown in Figure 22. The
protein was identified as a mixture of the α and β subunits of F1-ATPase.

The MALDI-TOF mass spectrum generated from the tryptic digest of the protein at about
~57 kDa in lane 4 of the SDS PAGE gel (Figure 22) is shown in Figure 25. Based upon the
molecular weights of the tryptic peptides generated from this protein, the protein was identified
as the mitochondrial isoform of HMG-CoA synthase. The mitochondrial form of this enzyme is
responsible for the biosynthesis of ketone bodies (Figure 26). The main tissue where ketogenesis
takes place is the liver; however, it has also been found in kidney, adipose tissue, and intestine.34
Ketone bodies act as an alternative glucose fuel in a number of tissues such as heart, muscle and
brain, and have a critical role during metabolic stress and starving. In patients with diabetes, this
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enzyme is overactive, producing too many ketone bodies which can lead to ketoacidosis, coma,
and death. Ketoacidosis is the lowering of the blood pH due to the overproduction of the acidic
ketone bodies which contain carboxylic acid functional groups. A MALDI-TOF spectrum for
the protein band at ~57 kDa in lane 2 of the gel was obtained which identified the protein as
mitochondrial HMG-CoA synthase, but a corresponding MALDI-TOF spectrum for this protein
in the bromo lanes 1 and 3 of the gel was not observed. It is difficult to determine if there is any
protein band present in lanes 1 and 3 for this protein, and even if there was, the concentration of
the protein was far too low to obtain a MALDI-TOF mass fingerprint spectrum. Therefore, this
protein is a candidate for specifically binding to the C-peptide beads. C-peptide may play a role
in inhibiting the production of excess ketone bodies when glucose levels are high in the
bloodstream.
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Figure 25. MALDI-TOF peptide fingerprint mass spectrum for the protein excised from the
band at ~57 kDa in lane 4 of the SDS-PAGE gel for bovine kidney shown in Figure 21. The
protein was identified as the mitochondrial isoform of HMG-CoA synthase.
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Figure 26. Ketone bodies synthesis pathway.35

Bovine Heart
The previous experiment was repeated (Figure 19), and the only change was the use of
bovine heart tissue instead of kidney tissue. Heart tissue was chosen for study because muscle
tissues are one of the main target organs of the insulin peptide. C-peptide does not appear to
directly alter glucose metabolism, 36 but it does appear that C-peptide and insulin-initiated
signaling cascades interact.37 Therefore, the heart may also be a target organ for the C-peptide.
The SDS-PAGE gel of the bovine heart proteins isolated using the bromo beads and the Cpeptide beads can be seen in Figure 27. There were distinct protein bands within the 37 kDa-75
kDa molecular weight range from both the bromo beads and the C-peptide beads for the
cytoplasmic protein lysates. These protein bands were excised from the gels, digested with
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trypsin, and identified by mass spectrometry using the mass fingerprint technique. The proteins
were identified as actin, α and β subunits of F1-ATPase, and HMG-CoA synthase. In this
experiment, there does seem to be a protein band in the bromo bead lane for the cytosplasmic
fraction that corresponds to the HMG-CoA synthase protein band in the C-peptide lane;
however, the MALDI-TOF spectra for this protein did not confirm the presence of HMG-CoA
synthase in the bromo lane, so this protein is still a candidate for specifically binding to the Cpeptide beads. There were also distinct protein bands within the 50 kDa-250 kDa molecular
weight range from the C-peptide beads for the cytoplasmic protein lysates.

Figure 27. SDS-PAGE gel of proteins isolated from bovine heart tissue. The first lane contains
molecular weight protein standards.
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The MALDI-TOF mass spectrum generated from the tryptic digest of the protein at about
~150 kDa in lane 4 of the SDS PAGE gel (Figure 27) is shown in Figure 28. Based upon the
molecular weights of the tryptic peptides generated from this protein, the protein was identified
as carbamoyl phosphate synthase. This protein is an enzyme that catalyzes the ATP dependent
synthesis of carbamoyl phosphate from glutamine or ammonia and bicarbonate. It represents the
first committed step in pyrimidine and arginine biosynthesis. Unfortunately, this protein was
also identified from the bromo beads lane in the nuclear protein lysates from the first trial using
bovine kidney tissue (Figure 21). Therefore, this protein is also not a good candidate for
specifically binding to the C-peptide beads.

Figure 28. MALDI-TOF peptide fingerprint mass spectrum for the protein excised from the
band at ~ 150 kDa in lane 4 of the SDS-PAGE gel for bovine heart shown in Figure 27. The
protein was identified as carbamoyl phosphate synthase.
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The protein band excised from the ~250 kDa position in lane 4 of the SDS-PAGE gel
(Figure 27) was identified as fatty acid synthase. The MALDI-TOF mass spectrum generated
from the tryptic digest of this protein is shown in Figure 29. This protein has not been
previously identified from the bromo lanes of any gels, and appears to be specifically isolated
from the C-peptide beads. Fatty acid synthase is a multi-enzyme protein that catalyzes the
synthesis of palmitic acid from acetyl-CoA and malonyl-CoA in the presence of NADPH. The
identification of this enzyme as a C-peptide binding protein is interesting, because C-peptide
may be influencing the activity of this enzyme. It could activate this enzyme to convert the
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excess glucose from the bloodstream metabolized to acetyl-CoA into a fatty acid for storage.
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Figure 29. MALDI-TOF peptide fingerprint mass spectrum for the protein excised from the
band at ~ 250 kDa in lane 4 of the SDS-PAGE gel for bovine heart shown in Figure 27. The
protein was identified as fatty acid synthase.
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The MALDI-TOF mass spectrum generated from the tryptic digest of the protein at about
~80 kDa in lane 4 of the SDS PAGE gel (Figure 27) is shown in Figure 30. Based upon the
molecular weights of the tryptic peptides generated from this protein, the protein was identified
as long chain fatty acid CoA ligase. This protein has not been previously identified from the
bromo lanes of any gels, and appears to be specifically isolated from the C-peptide beads. In
general, fatty acyl-CoA ligases are enzymes that activate long-chain fatty acids for both synthesis
of cellular lipids and degradation via beta-oxidation. There are several different isoforms of this
enzyme, and this isoform may activate fatty acids for the synthesis of triacylglycerol destined for
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Figure 30. MALDI-TOF peptide fingerprint mass spectrum for the protein excised from the
band at ~80 kDa in lane 4 of the SDS-PAGE gel for bovine heart shown in Figure 27. The
protein was identified as long chain fatty acid CoA ligase.
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Bovine Thymus
The previous experiment was repeated (Figure 19), and the only change was the use of
bovine thymus tissue instead of kidney tissue. There was no specific reason for using this tissue
type other than that it was easily obtained from the slaughter house. The SDS-PAGE gel of the
bovine thymus proteins isolated using the bromo beads and the C-peptide beads can be seen in
Figure 31. The protein bands from the cytoplasmic lysate are not well resolved, and this could
be because the lanes (especially the lysate only lane) were overloaded with protein. It was
decided to concentrate on the protein bands in the nuclear lysate.

Figure 31. SDS-PAGE gel of proteins isolated from bovine thymus tissue. The first lane
contains molecular weight protein standards.
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MALDI-TOF peptide mass fingerprint spectra were obtained for the protein bands in lane
4 of the gel (Figure 31) present at about 45 kDa, 52 kDa, 58 kDa, and 250 kDa. The mass
spectra confirmed that the proteins were actin, F1-ATPase, HMG-CoA synthase, and fatty acid
synthase just as previously identified in the heart and kidney lysates. The presence of actin in the
bromo lane (lane 3) of the gel was also confirmed by mass spectrometry.
NP-40 Protein Lysates
Multiple studies have shown that C-peptide binds to many different cell types, including
human skin fibroblasts, kidney tubule cells, and endothelial cells.6, 38-39 The C-peptide has been
shown to initiate signaling cascade consistent with C-peptide interacting with a GPCR, and the
actions of C-peptide in several cell systems were pertussis toxin sensitive.7,40 There was concern
that a cell membrane bound receptor protein in our lysates would be missed, because previous
lysates focused on cytoplasmic and nuclear proteins, not cell membrane bound proteins.
Therefore, it was decided to use an alternate method to lyse the tissue samples that included a
detergent that would help solubilize membrane bound proteins. A mild detergent was needed that
would solubilize the proteins without unfolding their tertiary structure. It was assumed that the
proteins would need to be folded into their native tertiary structure in order to interact and bind
to C-peptide. Therefore, the mild detergent NP-40 was chosen to lyse the tissue.
The basic experimental protocol for this experiment is summarized in Figure 32. The
only difference between this experiment and the previous experiment (Figure 19) was the way in
which the tissue samples were lysed. The SDS-PAGE gel of the bovine thymus proteins isolated
using the C-peptide beads can be seen in Figure 33. The lysates were precleared with the bromo
beads prior to incubation with the C-peptide beads. The protein bands marked with the arrows
on the gel were excised, digested with trypsin, and analyzed by mass spectrometry to obtain a
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peptide mass fingerprint spectrum for each protein. The molecular weights of the tryptic
peptides are summarized in Table 1. When the molecular weights were entered in Mascot, it was
determined that all four proteins were contaminated with keratin. Only the protein at ~40 kDa
could be positively identified as actin. There was a protein band at ~250 kDa that may have
been fatty acid synthase, but the keratin contamination made identification of this protein
impossible.

Figure 32. Basic experimental protocol for isolating proteins extracted from bovine thymus
using NP-40 lysis buffer with the C-peptide affinity beads.
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Figure 33. SDS-PAGE gel of proteins isolated from bovine thymus tissue using NP-40 lysis
buffer. Lane A contains molecular weight protein standards, lane B is bovine thymus proteins
isolated with C-peptide beads, and lane C is more concentrated bovine thymus proteins isolated
with C-peptide beads.

Tryptic Peptide
Tryptic Peptide
Tryptic Peptide
Tryptic Peptide Mass
Mass Fingerprint for Mass Fingerprint for Mass Fingerprint for Fingerprint for Protein
Protein at ~10 kDa
Protein at ~40 kDa
Protein at ~60 kDa
at ~150 kDa
Measured in Da

Measured in Da

Measured in Da

989.6
1274.8
1266.0
1475.9
1635.0
1639.0
1744.0
1994.2
2211.2
-

1198.8
1277.8
1475.8
1516.9
1791.1
1954.2
1994.2
2211.4
-

1060.8
1277.8
1476.0
1941.2
2211.5
842.6
1480.0
2283.5
-

Measured in Da
1060.8
1179.8
1234.9
1278.0
1303.0
1307.9
1476.0
1639.2
1708.1
3053.2

1791.2
1839.2
1852.2
1994.4
2150.5
2211.5
2399.5
2705.8
2873.0
-

Table 1. Molecular weights of tryptic peptides obtained from the mass spectra of the four protein
bands excised from the gel shown in Figure 32.
This experiment was repeated with bovine thymus tissue, and we also lysed rat liver
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tissue and human cheek cells were also lysed. The SDS-PAGE gel of the proteins isolated using
the C-peptide beads can be seen in Figures 34 and 35. Again, good enough mass fingerprint
spectra for any protein bands were unattainable. These experiments with the NP-40 lysis buffer
need to be repeated in future studies. Not any good protein bands on the SDS-PAGE gels were
obtained using this procedure. The lysis protocol using NP-40 detergent may need to be adjusted
to ensure that the proteins remain folded in their native tertiary structures.

A

B

C

D

250
150
100
75

Figure 34. SDS-PAGE separation of proteins eluted from the C-peptide beads using human
cheek lysate, rat liver lysate and bovine thymus lysate. Lane A is the protein markers. Lane B is
the cheek lysate. Lane C is the rat liver lysate. Lane D is the bovine thymus lysate.
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Figure 35. SDS-PAGE separation of proteins eluted from the C-peptide beads using rat liver
lysate and bovine thymus lysate. Lane A is the protein markers. Lane B is the rat liver lysate.
Lane C is the bovine thymus lysate.

CONCLUSIONS
In all the experiments, one common theme persisted. Most of the proteins isolated with
the C-peptide beads tended to be the same molecular weights, even when different tissue types
were used. A number of these reoccurring protein bands that were shared among the different
gels were excised, and the proteins were identified using the peptide mass fingerprint technique.
Table 2 is a list of the proteins identified indicating their location within the cell and their general
cellular function.
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Name
Actin

Weight in kDa
~45

Cellular Location
Cytoplasmic

CPS I

~165

Mitochondria

F1-ATPase

~51

Mitochondria

Long chain fatty acid
CoA ligase
Fatty acid synthase

~80

Mitochondria

~250

HMG-CoA synthase

~57

Cytoplasmic

Cytoplasmic

Cellular Function
muscle contraction,
cell motility, cell
division and
cytokinesis, vesicle
and organelle
movement, cell
signaling, and
establishment and
maintenance of cell
junctions and cell
shape, etc.
urea cycle-removes
excess ammonia from
cells
catalyze synthesis of
ATP during oxidative
phosphorylation
lipid biosynthesis
central enzyme in de
novo lipogenesis.
FAS is a target for
SREBP and is
upregulated by LXR
activation; it is also
one of the accepted
markers for insulin
resistance, SREBP
and LXR activation.
Ketone body
synthesis. This
enzyme condenses
acetyl CoA with
acetoacetyl CoA to
form HMG CoA,
which is the substrate
for HMG CoA
reductase.

Table 2. Table of proteins identified in this study indicating their cellular location and function.
* All information obtained from www.abcam.com and www.sbct.com.
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Most of these proteins were isolated from the nuclear lysate fractions, however, most of
the identified proteins are normally cytoplasmic proteins. The fact that they were isolated from
the nuclear fractions most likely indicates that differential lysis of the cells was not entirely
successful. The procedure used for lysis works best with cultured cells, but tissue was being
used in these studies. Some of these proteins may also be located in the nucleus of cells under
special conditions, but most likely there were cytosolic proteins mixed in with the nuclear
protein lysates.
The isolation of both fatty acid synthase and long chain fatty acyl-CoA ligase indicates
that C-peptide may play a role in stimulating the production of fatty acids from excess glucose
and converting those fatty acids to triacylglycerides for storage inside muscle cells. C-peptide
does not appear to directly alter glucose metabolism 36, 41, but it does interact with insulininitiated signaling cascades which is important for the normal functioning of both peptides.
Accumulating evidence suggests that lipid metabolism is as or more important to diabetes than
carbohydrate metabolism. Insulin is an important regulator of fatty acid synthase. Insulin
upregulates the expression of fatty acid synthase in murine cell lines and primary human
adipocytes and increases fatty acid synthase enzymatic activity.42 In addition, insulin resistance
has been shown to impair the process of de novo lipogenesis in adipose tissue. C-peptide has a
half-life in serum of about 30 minutes, which is much longer than insulin’s half-life of about 3
minutes.43 Perhaps C-peptide helps to fine tune the effect of insulin on fatty acid synthase and
extend the effects to a longer time frame. In addition, C-peptide may be more targeted to muscle
cells than liver cells. C-peptide escapes first-pass metabolism by the liver indicating that it may
not enter liver cells as readily as other cell types. The results of this study indicate that C-peptide
may be more involved in modulating lipid metabolism within cells. It may play a role in
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determining the fate of the excess glucose that enters cells by stimulating the production of fatty
acids and conversion of those fatty acids to triacylglycerides for short-term intracellular storage
instead of sending the fatty acids to the adipose tissue for long-term storage.
FUTURE
Even though some interesting results were obtained for this experiment, there is still a lot
of work to be done on this project. The experiments using the NP-40 lysis buffer need to be
repeated, and a better protocol for this lysis needs to be established to ensure the proteins remain
folded in their native tertiary structure. Sequencing a few of the peptides in order to confirm
protein identifications, especially for the fatty acid synthase protein and the long chain acyl-CoA
ligase protein, is needed before this work can be published. In addition, it would be best to
repeat the entire cytoplasmic and nuclear lysis procedure (Figure 19) using human tissue or
human cell lines since human C-peptide was used to make the C-peptide affinity beads.
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APPENDIX A
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APPENDIX B
EXPERIMENTAL PROTOCOLS

A.

Making Beads Pre-clearing
1. Beads swell in DCM for 1 hour.
2. Wash beads with DMF two times.
3. Let beads sit in lysis buffer until further use.

B.

Making Beads with Peptide Attached
1. Beads swell in DCM for 1 hour.
2. Wash beads with DMF two times.
3. Remove supernatant and discard.
4. Add in 150 µL of 0.1 M NaOH to 150 µL of H2O and then add a small amount of
peptide.
5. Incubate for 1-2 hours.
6. Remove supernatant and wash beads with DCM three times, DMF three
times, and lysis buffer three times.

C.

Cell Lysate Preparation
1. Add harvested cells to 1 mL of lysis buffer in a clean siliconized tube,
making sure to be kept on ice.
2. Add in the Protease Cocktail Inhibitors to the tube.
1 µL of aproptin
1µL of pepstatin
3. Vortex for about 5 minutes.
4. Sonicate for about 5 minutes
5. Put onto shaker, on ice, for about 30 minutes to an hour to let the lysate
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incubate.
6. Centrifuge and remove the supernatant to keep for the following
pre-clearing process part D.
D.

Pre-clearing Process
1. Take the cell lysate and add to 30 µL of pre-clearing beads that are in the lysis
buffer.
2. Incubate for 1 hour.
3. Remove supernatant and keep for part E.

E.

Experimental Procedure
1. Take the pre-cleared cell lysate and add to 30 µL of the beads with peptide
attached.
2. Incubate 1-2 hours.
3. Remove supernatant and keep to retrieve peptide at a later date.
4. Wash beads twice with PBS.
5. Add 30 µL of SDS-PAGE loading buffer with DTT to the beads.
6. Heat for 10 minutes in boiling water.
7. Load 12 µL of Precision Plus Protein Standards kaleidoscope onto the first lane of
the SDS-PAGE electrophoresis gel.
8. By skipping a lane(s), load 27 µL of each sample(s) onto the gel. Add enough
Tris/Glycine/SDS Buffer to cover the gel and the surrounding area.
9. Run the gel to completion ~45 minutes to an hour at 200 V and keep for
analyzing.
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F.

Steps to Prepare for Analyzing
1. Make sure to wear gloves and never touch the gel with your hands, disassemble
the electrophoresis apparatus. Take the gel out and be careful not to tear it.
2. Wash the gel a few times with distilled water to wash off all of the SDS-Page
Buffer Solution.
3. Add enough Coomassie Blue Stain to cover the gel.
4. Let it sit on the shaker overnight.
5. Wash the gel with distilled water to remove the stain.
6. Unless used immediately, cover with enough distilled water to cover the gel and
put into freezer for further analysis.

G.

In Gel Digestion Procedures
1. Prepare the following solutions:
-25 mM NH4HCO3 (100 mg/50 mL)
-25 mM NH4HCO3 in 50% ACN
-50% ACN/ 50% formic acid
-12.5 mg/µL trypsin in 25 mM NH4HCO3 (freshly diluted)
2. Dice each gel slice into small pieces and place into clean dry Eppendorf
tube.
3. Add ~100 µL (or enough to cover) of NH4HCO3 in 50% ACN and vortex for a
few minutes.
4. Using gel loading pipet tip, extract and discard the supernatant.
5. Repeat steps 3 and 4 once or twice more.

-For low level proteins (<1pmol) especially those separated by 1-D SDS-PAGE, reduction and
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alkylation is recommended.
The following procedures are preformed after step 5.
Prepare the following fresh solutions 5a-5f.
a.

10 mM DTT (1.5 mg/mL) in 25 mM NH4HCO3 ( 1.5mg/mL)
55 mM iodacetamide in 25 mM NH4HCO3 (10 mg/µL)

b.

Add 25 µL (or enough to cover) 10 mM DTT in 25 mM NH4HCO3
to dried gels. Vortex and spin briefly, allow 1 hour at 56 ºC for
reaction to proceed.

c.

Remove supernatant and discard. Add 25 µL 55 mM
iodoacetamide to the gel pieces. Vortex and spin briefly. Allow
reaction to proceed in the dark at room temperature for 45 minutes.

d.

Remove supernatant and discard. Wash gels with ~100 µL 25 mM
NH4HCO3 . Vortex for 10 minutes and spin.
Remove supernatant and discard. Dehydrate gels with ~100 µL (or
enough to cover) of 25 mM NH4HCO3 in 50 % ACN. Vortex for 5
minutes and spin. Repeat once.

e.

Proceed with trypsin digest.

6. Add trypsin solution to just barely cover the gel pieces. Estimate the gel
volume and add about 3 times the volume of trypsin solution. This volume
will vary from sample to sample, but on average ~5-25 µL is sufficient.
7. Rehydrate the gel pieces at 4 ºC for 10 minutes. Spin. Add 25
mM NH4HCO3 as needed to cover the gel pieces
8. Spin briefly and incubate at 37 ºC (room temperature) for overnight.
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H.

Extraction of Peptides
**KEEP ALL LIQUIDS**
1. Transfer the digest solution (aqueous extraction) into a clean 0.65 mL
siliconized tube.
2. To the gel pieces add 30 µL (or enough to cover) of 50 % ACN/ 5 % formic acid.
3. Vortex for 20-30 minutes, spin, and sonicate. Repeat.
4. Vortex the extracted digests, spin, and speedvac to reduce the volume to
around 10 µL.
5. Either proceed with C18 ZipTip (Millipore) cleanup or analyze using LCMS.

I.

C18 ZipTip
When analyzing low levels of protein, concentrate the peptides by eluting them from
ZipTips. Use 3 µL of elution solution in a clean 0.65 mL siliconized tube. Utilize 1
µL of the unseparated digest for analysis by MALDI.

You have tubes filled with your samples of extracted peptides. In each tube, using the
same C18 ZipTip do the following:
1.

Pull up 10 µL of ACN into the C18 ZipTip and discard. Repeat.

2.

Pull up 10 µL of 80 % ACN into the ZipTip and then discard. To dilute to 80 %
use 800 µL of ACN and 200 µL of TFA to get the solution.

3.

Pull up 10 µL of 0.1 % TFA into the ZipTip and discard. Repeat.

4.

Pull up 10 µL of sample and discard into its same tube 10 times.

5.

Pull up 10 µL of 0.1 % TFA into the ZipTip and discard. Repeat twice.
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6.

Pull up 5 µL of 80 % ACN into the ZipTip and discard into a clean siliconized
tube. Keep for analysis by MALDI-TOF.

J.

CelLytic™ Nuclear NuCLEAR™ Extraction Kit from Sigma
Nuclear Protein Extraction from 100 mg of tissue
Calculate accordingly for different tissue weight
1. Dilute the 1 M DTT solution to 0.1 M with deionized, sterile water.
2. Prepare 1x lysis buffer, hypotonic
a. To 1 mL of 1x lysis buffer
Add:10 µl of the prepared 0.1 M DTT solution
10 µl of the protease cocktail inhibitor
3. Rinse tissue twice with PBS and discard PBS.
4. Resuspend tissue in 1 mL of the 1x lysis buffer (containing DTT and
protease inhibitors.
5. Homongenize the tissue until more than 90 % of the cells are broken.
6. Centrifuge the disrupted cells for 20 minutes at 10,000-11,000 x g.
7. Transfer the supernatant to a fresh tube. (This portion is called the
cytoplasmic fraction.)
8. Add 1.5 mL of the prepared 0.1 M DTT solution and 1.5 mL of the
protease cocktail inhibitor to 147 mL of the extraction buffer.
9. Resuspend the crude nuclei pellet in ~140 mL extraction buffer containing
DTT and protease inhibitor
10. Shake gently in refrigerator for 30 minutes.
11. Centrifuge for 5 minutes at 20,000-21,000 x g.
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12. Transfer the supernatant to a clean, chilled tube. (This portion is called
the nuclear fraction.)
K.

Making Lysis Buffer
To make 40 mL of Buffer:
1. 20 mL H2O
2. 0.08 mL EDTA
3. 0.10 mL Tris
4. 4 mL Glycerol
5. 0.04 mL NP40
6. pH needs to be around 7.5
7. QS with H20 at 40 mL
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